经中心静脉导管微创引流控制胸腔积液  

Pleural effusion controlled by interrupted drainage via central venous catheter

作　　者：程国玲[1] 韩明锋[1] 滕晓宝[1] 时靖峰[1] 李强[1] 许靖[1] 

机构地区：[1]安徽省阜阳市第二人民医院呼吸科,阜阳236015

出　　处：《临床医学》2010年第8期4-5,共2页Clinical Medicine

摘　　要：目的探讨利用经皮中心静脉导管微创引流控制胸腔积液的效果及优点。方法 66例经皮中心静脉导管微创引流患者为研究组,同期48例常规胸腔穿刺抽液患者为对照组,对两组患者的胸腔积液控制时间、平均住院日、穿刺次数、专项治疗费用及穿刺不良事件等方面进行观察和比较。结果研究组的人均胸腔穿刺次数、胸腔积液消失天数、平均住院天数、专项治疗费用及人均穿刺不良事件发生率分别为1.11次、(4.0±2.6)d、(9.6±3.0)d、(256±45)元和12.1%,对照组分别为4.08次、(8.9±3.1)d、(15.7±4.2)d、(432±57)元和31.3%,两组比较差异均有统计学意义(P<0.01或0.05)。结论经中心静脉导管微创引流是控制胸腔积液简便经济且创伤小的有效方法,值得临床推广。Objective To explore therapeutic effect,advantages and shortcomings of pleural effusion controlled by interrupted drainage via central venous catheter.Methods The research group had 66 cases of pleural effusion controlled by interrupted drainage via central venous catheter,the control group had 48 cases with pleural effusion controlled by conventional pleuracentesis.We observed pleural effusion disappearing time,average hospitalization time,pleuracentesis frequency,related therapy expenses and complications of two groups and compared them.Results The pleural effusion disappearing time,average hospitalization time,pleuracentesis frequency,related therapy expenses and per capita incidence of complications of the research group were 1.11 times,（4.0±2.6） days,（9.6±3.0）days,（256±45） yuan and 12.1% respectively;the control group were 4.08 times,（8.9±3.1）days,（15.7±4.2）days,（432±57） yuan and 31.3% respectively.The differences between the two groups were particularly remarkable（P0.01 or P0.05）.Conclusion The therapy of pleural effusion controlled by interrupted drainage via central venous catheter is safe,convenient,ecomomical and microtraumatic,it is worth of being a wider use.

关 键 词：中心静脉导管 胸腔积液 胸腔穿刺术 结核性胸膜炎 肺癌 

分 类 号：R561[医药卫生—呼吸系统]